{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:15:33Z","timestamp":1791422133309,"version":"4.3.3"},"reference-count":36,"publisher":"Impact Journals, LLC","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,29]]},"DOI":"10.18632\/oncotarget.6285","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T05:13:13Z","timestamp":1446527593000},"page":"44892-44904","source":"Crossref","is-referenced-by-count":53,"title":["Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response"],"prefix":"10.18632","volume":"6","author":[{"given":"Carole","family":"Achard","sequence":"first","affiliation":[{"name":"INSERM, UMR892, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"CNRS, UMR6299, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Boisgerault","sequence":"additional","affiliation":[{"name":"INSERM, UMR892, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"CNRS, UMR6299, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Delaunay","sequence":"additional","affiliation":[{"name":"INSERM, UMR892, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"CNRS, UMR6299, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Roulois","sequence":"additional","affiliation":[{"name":"INSERM, UMR892, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"CNRS, UMR6299, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Nedellec","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Nantes, Nantes, France"},{"name":"INSERM UMS016, SFR Sant\u00e9, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Joseph","family":"Royer","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Nantes, Nantes, France"},{"name":"INSERM UMRS1087, Institut du Thorax, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory","family":"Pain","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Nantes, Nantes, France"},{"name":"INSERM UMRS1087, Institut du Thorax, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Combredet","sequence":"additional","affiliation":[{"name":"CNRS UMR3569, Unit\u00e9 de G\u00e9nomique Virale et Vaccination, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Mesel-Lemoine","sequence":"additional","affiliation":[{"name":"CNRS UMR3569, Unit\u00e9 de G\u00e9nomique Virale et Vaccination, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Cellerin","sequence":"additional","affiliation":[{"name":"CHU de Nantes, Service d'Oncologie M\u00e9dicale Thoracique et Digestive, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Magnan","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Nantes, Nantes, France"},{"name":"INSERM UMRS1087, Institut du Thorax, Nantes, France"},{"name":"CHU de Nantes, Service de Pneumologie, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Tangy","sequence":"additional","affiliation":[{"name":"CNRS UMR3569, Unit\u00e9 de G\u00e9nomique Virale et Vaccination, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gr\u00e9goire","sequence":"additional","affiliation":[{"name":"INSERM, UMR892, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"CNRS, UMR6299, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Fonteneau","sequence":"additional","affiliation":[{"name":"INSERM, UMR892, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"CNRS, UMR6299, Institut de Recherche en Sant\u00e9 de l'Universit\u00e9 de Nantes, Nantes, France"},{"name":"Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Bell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"2","first-page":"587","article-title":"Antitumor virotherapy by attenuated measles virus (MV)","volume":"2","author":"Fonteneau","year":"2013","journal-title":"Biology (Basel)"},{"key":"3","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2174\/138920112800958896","article-title":"Attenuated oncolytic measles virus strains as cancer therapeutics","volume":"13","author":"Galanis","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"4","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1182\/blood-2004-11-4558","article-title":"Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responsesand targets interferon-resistant tumor cells","volume":"106","author":"Dummer","year":"2005","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/0008-5472.CAN-09-2762","article-title":"Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer","volume":"70","author":"Stanhope","year":"2010","journal-title":"Cancer Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/0008-5472.CAN-14-2533","article-title":"Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer","volume":"75","author":"Keeney","year":"2015","journal-title":"Cancer Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-04-0884","article-title":"High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus","volume":"64","author":"Peng","year":"2004","journal-title":"Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain)","volume":"75","author":"Richardson","year":"1993","journal-title":"Cell"},{"key":"9","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1128\/JVI.67.10.6025-6032.1993","article-title":"Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus","volume":"67","author":"Gerlier","year":"1993","journal-title":"J Virol"},{"key":"10","first-page":"45","article-title":"Membrane cofactor protein","volume":"178","author":"Atkinson","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0161-5890(03)00112-3","article-title":"Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors","volume":"40","author":"Kirschfink","year":"2003","journal-title":"Mol Immunol"},{"key":"12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1600-0714.2006.00466.x","article-title":"Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas","volume":"35","author":"Shuler","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"13","first-page":"4656","article-title":"Intraperitoneal therapy of ovarian cancer using an engineered measles virus","volume":"62","author":"Russell","year":"2002","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature10639","article-title":"Adherens junction protein nectin-4 is the epithelial receptor for measles virus","volume":"480","author":"Cattaneo","year":"2011","journal-title":"Nature"},{"key":"15","doi-asserted-by":"crossref","first-page":"e1002240","DOI":"10.1371\/journal.ppat.1002240","article-title":"Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus","volume":"7","author":"Richardson","year":"2011","journal-title":"PLoS Pathog"},{"key":"16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/JTO.0000000000000214","article-title":"Measles vaccine strains for virotherapy of non-small-cell lung carcinoma","volume":"9","author":"Kratzke","year":"2014","journal-title":"J Thorac Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/ijo.2013.1914","article-title":"Primary resistance phenomena to oncolytic measles vaccine viruses","volume":"43","author":"Lauer","year":"2013","journal-title":"Int J Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/JVI.02106-12","article-title":"Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis","volume":"87","author":"Lauer","year":"2013","journal-title":"J Virol"},{"key":"19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Rice","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.mib.2013.04.005","article-title":"An evolutionary perspective on the broad antiviral specificity of MxA","volume":"16","author":"Malik","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"21","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1158\/0008-5472.CAN-07-6265","article-title":"Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response","volume":"68","author":"Gregoire","year":"2008","journal-title":"Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1078-0432.CCR-12-2733","article-title":"Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells","volume":"19","author":"Gregoire","year":"2013","journal-title":"Clin Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajpath.2010.12.014","article-title":"Identification of novel markers for the diagnosis of malignant pleural mesothelioma","volume":"178","author":"Gregoire","year":"2011","journal-title":"Am J Pathol"},{"key":"24","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1099\/0022-1317-83-6-1431","article-title":"Analysis of receptor (CD46, CD150) usage by measles virus","volume":"83","author":"Schneider-Schaulies","year":"2002","journal-title":"J Gen Virol"},{"key":"25","doi-asserted-by":"crossref","first-page":"e1004081","DOI":"10.1371\/journal.ppat.1004081","article-title":"ligands of MDA5 and RIG-I in measles virus-infected cells","volume":"10","author":"Hopfner","year":"2014","journal-title":"PLoS Pathog"},{"key":"26","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Schreiber","year":"2011","journal-title":"J Exp Med"},{"key":"27","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells","volume":"208","author":"Gajewski","year":"2011","journal-title":"J Exp Med"},{"key":"28","doi-asserted-by":"crossref","first-page":"e50692","DOI":"10.1371\/journal.pone.0050692","article-title":"Influence of genetic variants in type I interferon genes on melanoma survival and therapy","volume":"7","author":"Kumar","year":"2012","journal-title":"PLoS One"},{"key":"29","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1128\/JVI.69.7.4506-4510.1995","article-title":"Enhanced virus resistance of transgenic mice expressing the human MxA protein","volume":"69","author":"Haller","year":"1995","journal-title":"J Virol"},{"key":"30","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1128\/JVI.68.11.6910-6917.1994","article-title":"Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells","volume":"68","author":"ter Meulen","year":"1994","journal-title":"J Virol"},{"key":"31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nature12862","article-title":"Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity","volume":"505","author":"Garcia-Sastre","year":"2014","journal-title":"Nature"},{"key":"32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Rice","year":"2011","journal-title":"Nature"},{"key":"33","first-page":"387362","article-title":"Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas","volume":"2013","author":"Gregoire","year":"2013","journal-title":"Biomed Int Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.mayocp.2014.04.003","article-title":"Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy","volume":"89","author":"Dispenzieri","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1164\/rccm.200811-1730OC","article-title":"Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1","volume":"180","author":"Knight","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"11546","DOI":"10.1128\/JVI.77.21.11546-11554.2003","article-title":"A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice","volume":"77","author":"Tangy","year":"2003","journal-title":"J Virol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T18:33:04Z","timestamp":1589394784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,2]]},"references-count":36,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2015,12,29]]}},"alternative-id":["6285","26539644"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6285","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,2]]}}}